Goforth v. Bristol-Myers Squibb Company et al

Filing 11

CONDITIONAL TRANSFER ORDER (CTO-1) directing the Clerk of Court to transfer this case to the Eastern District of Kentucky as part of MDL No. 2809. Signed by the Clerk of the Panel, Jeffery N. Luthi on 2/15/2018. (mef)

UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION

IN RE: ONGLYZA (SAXAGLIPTIN) AND
KOMBIGLYZE XR (SAXAGLIPTIN AND
METFORMIN) PRODUCTS LIABILITY
LITIGATION

MDL No. 2809

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO −1)

On February 2, 2018, the Panel transferred 39 civil action(s) to the United States District Court for
the Eastern District of Kentucky for coordinated or consolidated pretrial proceedings pursuant to 28
U.S.C. § 1407. See _F.Supp.3d_ (J.P.M.L. 2018). Since that time, no additional action(s) have been
transferred to the Eastern District of Kentucky. With the consent of that court, all such actions have
been assigned to the Honorable Karen K Caldwell.
It appears that the action(s) on this conditional transfer order involve questions of fact that are
common to the actions previously transferred to the Eastern District of Kentucky and assigned to
Judge Caldwell.
Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict
Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the
Eastern District of Kentucky for the reasons stated in the order of February 2, 2018, and, with the
consent of that court, assigned to the Honorable Karen K Caldwell.
This order does not become effective until it is filed in the Office of the Clerk of the United States
District Court for the Eastern District of Kentucky. The transmittal of this order to said Clerk shall
be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the
Panel within this 7−day period, the stay will be continued until further order of the Panel.

FOR THE PANEL:
Feb 13, 2018

Jeffery N. Lüthi
Clerk of the Panel

FILED AND CERTIFIED
ROBERT R. CARR, CLERK
U.S. DISTRICT COURT
EASTERN DISTRICT OF KENTUCKY
Date:
By:

Deputy Clerk

IN RE: ONGLYZA (SAXAGLIPTIN) AND
KOMBIGLYZE XR (SAXAGLIPTIN AND
METFORMIN) PRODUCTS LIABILITY
LITIGATION

MDL No. 2809

SCHEDULE CTO−1 − TAG−ALONG ACTIONS

DIST

DIV.

C.A.NO.

CASE CAPTION

17−02024
17−02056

Hardy v. Bristol−Myers Squibb Company et al
Lacy v. Bristol−Meyers Squibb Company et al

17−00736

Goforth v. Bristol−Myers Squibb Company et al

3

17−03110

Veloria v. Bristol−Myers Squibb Company et al

1

17−02798

Driver v. Bristol−Meyers Squibb Company et al

17−02095

Garcia v. Bristol−Myers Squibb Company et al

17−00860

MASK v. BRISTOL−MYERS SQUIBB COMPANY et
al

17−24379

Holmes v. Astrazeneca Pharmaceuticals LP et al

17−04342
17−04934
17−00155

Green v. Bristol−Myers Squibb Company et al
Harris v. Bristol−Myers Squibb Company et al
Nance v. Brystol−Myers Squibb Company et al

ALABAMA NORTHERN
ALN
ALN

2
7

ARKANSAS EASTERN
ARE

4

ARKANSAS WESTERN
ARW
COLORADO
CO

FLORIDA MIDDLE
FLM

6

FLORIDA NORTHERN
FLN

3

FLORIDA SOUTHERN
FLS

1

GEORGIA NORTHERN
GAN
GAN
GAN

1
1
3

GAN
GAN

3
3

17−00156
17−00157

Merritt v. Bristol−Myers Squibb Company et al
Hayes v. Bristol−Myers Squibb Company et al

18−01015

Adams v. Bristol−Myers Squibb Company et al

17−00207

BEELER v. BRISTOL−MYERS SQUIBB COMPANY
et al

17−00180

Barner v. Bristol−Myers Squibb Company et al

17−12986

Jones v. Bristol−Myers Squibb Company, et al

3
6

17−01535
17−01501

Winborne v. Bristol−Myers Squibb Co et al
Sandoval v. Bristol−Myers Squibb Co et al

1

17−02974

Ellis v. Bristol−Myers Squibb Company et al

ILLINOIS CENTRAL
ILC

1

INDIANA SOUTHERN
INS

4

KENTUCKY WESTERN
KYW

5

LOUISIANA EASTERN
LAE

2

LOUISIANA WESTERN
LAW
LAW
MARYLAND
MD

MISSISSIPPI NORTHERN
MSN

1

17−00207

Stacy v. Bristol−Myers Squibb Company et al

17−02867

Turner v. Bristol−Myers Squibb Company et al

2

18−04001

Lyles v. Bristol−Myers Squibb Company, et al

NJ

3

17−03027

NJ

3

17−03031

NJ

3

17−04533

WOODS v. BRISTOL MEYERS SQUIBB COMPANY
et al
WILLIAMS v. BRISTOL MYERS SQUIBB
COMPANY et al
JOHNSON v. BRISTOL−MEYERS SQUIBB
COMPANY et al

18−00190

Caldwell v. Bristol−Myers Squibb Company, et al

MISSOURI EASTERN
MOE

4

MISSOURI WESTERN
MOW
NEW JERSEY

OHIO NORTHERN
OHN

3

OHN
OHN

4
5

17−02573
17−02333

Campbell v. Bristol−Myers Squibb Company et al
Dinger Sr. v. Bristol−Myers Squibb Company et al

17−00409

McCall v. Bristol−Myers Squibb Company et al

17−03167
17−03297

Winkle v. Bristol−Myers Squibb Company et al
Epps v. Bristol−Myers Squibb Company et al

17−02808
17−02810
17−02812

Jackson v. Bristol−Myers Squibb Company et al
Silvers v. Bristol−Myers Squibb Company et al
Word v. Bristol−Myers Squibb Company et al

17−03028
17−00888
17−00253
17−00278

Carter v. Bristol−Myers Squibb Company et al
Davis v. Bristol−Myers Squibb Company et al
Rosencranse v. Bristol−Myers Squibb Company et al
Lynn v. Bristol−Myers Squibb Company et al

4

17−03321

Slaughter v. Bristol−Myers Squibb Company et al

1

17−00179

Medley v. Bristol−Myers Squibb Company et al

OKLAHOMA EASTERN
OKE

6

SOUTH CAROLINA
SC
SC

2
4

TENNESSEE WESTERN
TNW
TNW
TNW

2
2
2

TEXAS NORTHERN
TXN
TXN
TXN
TXN

3
4
5
5

TEXAS SOUTHERN
TXS
UTAH
UT